| Value | ₹8.18 Cr |
|---|---|
| Execution period | Vesting starts after 1 year, with an exercise period up to 1 year from vesting. |
NSE filing, NSE: KANPRPLA. Summary written from the filing by ALFA Finder's alert engine.
Kanpur Plastipack Ltd: key numbers
- Share price
- ₹248.94
- Market cap
- ₹611.7 Cr
- Revenue (annual)
- ₹718.8 Cr
- Net profit (annual)
- ₹39.49 Cr
- P/E (TTM)
- 11.4×Sector 43.1×
- Promoter holding
- 68.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kanpur Plastipack Ltd
All →Kanpur Plastipack Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹2,402.2 Mn (+44.2%), EBITDA ₹266.2 Mn (+58.5%), PAT ₹160.6 Mn (+102.1%), EBITDA margin 11.1%. Strategy: FIBC scale-up, Taslan yarn, non-wovens, UK/Italy expansion.
Kanpur Plastipack Results Update
Kanpur Plastipack reported consolidated revenue, EBITDA and PAT growth of about 44%, 59% and 102% year-on-year in Q2 FY27. The company flagged rainfall-related delays to two expansion projects.
Kanpur Plastipack Management Change
Kanpur Plastipack appointed Sanjiv Swarup as an Additional Independent Director effective October 27, 2026. His regularisation for five years will go to shareholders later.
Kanpur Plastipack Q2 FY27 Results: Net Profit ₹16.1 Cr, Up 109.1% YoY
Kanpur Plastipack Ltd reported revenue from operations of ₹236.3 Cr (+43.0% YoY) and net profit of ₹16.1 Cr (+109.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹16.1 Cr · +109.1% YoY
Kanpur Plastipack Other Announcement
Kanpur Plastipack Limited filed the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Kanpur Plastipack Board Meeting Date
Kanpur Plastipack intimated a board meeting on 27 October 2026 to consider Q1 FY27 financial results. No transaction or monetary value is disclosed in this advance notice.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date